Skip to main content
Logo
  • About Us
    • Our Leadership
    • Diversity, Equity & Inclusion
    • Collaborations
    • Compliance & Ethics
    • Corporate Giving
  • Our Focus
    • Beta-Thalassemia
    • Cerebral Adrenoleukodystrophy
    • Sickle Cell Disease
  • Our Science
    • Our Approach to Gene Therapy
    • Our Treatment Process
    • Our Pipeline
    • Clinical Trials
  • Our Therapies
  • Patients & Advocacy
    • Patient Advocacy
    • Patient Resources
    • Access Policy
  • Investors & Media
  • Contact Us
  • Careers

sitemap

About Us

Our Leadership

Collaborations

Compliance & Ethics

Corporate Giving

Our Focus

Beta-Thalassemia

Cerebral Adrenoleukodystrophy

Sickle Cell Disease

Our Science

Our Approach to Gene Therapy

Our Treatment Process

Our Pipeline

Clinical Trials 

Our Therapies

Patients & Advocacy

Patient Advocacy

Patient Resources

Access Policy 

Contact Us

Investors & Media

Careers

You are now leaving www.bluebirdbio.com

Links to sites outside of this website are provided as a resource to the viewer. bluebird bio accepts no responsibility for the content of linked sites.

Continue
You are now leaving www.bluebirdbio.com to go to another bluebird bio site.
Continue
bluebird bio's company logo

QUICK LINKS

patients & advocacy

investors & media

careers

contact us

CONTACT INFO

info@bluebirdbio.com

clinicaltrials@bluebirdbio.com

investor@bluebirdbio.com

medinfo@bluebirdbio.com

  • Terms of Service
  • Privacy Policy
  • Cookie Notice
  • Community Guidelines
  • Sitemap
© 2023 bluebird bio, Inc. All Rights Reserved. Corp-US-00175-V5 09/22
  • twitter bird icon
  • linkedin icon
  • youtube icon
  • instagram icon
  • glassdoor icon